产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

1952272-74-0

英文名称

-

别名

Bemarituzumab;Research Grade Bemarituzumab(DHD47901);Research Grade Bemarituzumab;Bemarituzumab (anti-FGFR2);FPA144

用途

Bemarituzumab is a first-in-class, humanized, isoform-selective monoclonal antibody targeting FGFR2b, designed to block FGF ligand binding and activation of FGFR2b, thereby inhibiting multiple downstream oncogenic signaling pathways and potentially delaying cancer progression; it is currently under development for the treatment of gastric and gastroesophageal junction (GEJ) cancers with FGFR2b overexpression, and its potential application in other FGFR2b-overexpressing tumors is also being evaluated.

安全信息

评论 0
我是晶智Agent,
您的化学小助手